Wellington Management Group
BLUE

Wellington Management Group’s bluebird bio BLUE Stock Holding History

Wellington Management Group’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-55
Closed -$3.04M – 2212
2017
Q3 		$3.04M Buy
55
+28
+104% +$39.1K ﹤0.01% 1614
2017
Q2 		$1.29M Sell
27
-8
-23% -$9.65K ﹤0.01% 1819
2017
Q1 		$1.32M Buy
+35
New +$35.7K ﹤0.01% 1851

Other funds holding BLUE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group's BLUE Position: Q2 2024 in Review

Wellington Management Group sold out of bluebird bio (BLUE) in Q2 2024, closing a stake of 33,019 shares — an estimated $845K sold.

Wellington Management Group first reported a position in BLUE in Q4 2014 and held it in 36 quarters. The position peaked at $1.15B in Q1 2019. 150 funds tracked by Wall St. Rank hold BLUE as of Q2 2024.

  • Wellington Management Group reported no remaining bluebird bio position as of Q2 2024 after selling out during the quarter.
  • Wellington Management Group sold 33,019 bluebird bio shares in Q2 2024, an estimated $845K.
  • Wellington Management Group first reported a position in bluebird bio in Q4 2014 and held it in 36 quarters.
  • Wellington Management Group's bluebird bio position peaked at $1.15B in Q1 2019.
  • 150 funds tracked by Wall St. Rank held bluebird bio as of Q2 2024.

Based on Wellington Management Group's 13F filing for Q2 2024, filed 14 Aug 2024.